innopain.comAbout company
Innopain is a biopharmaceutical company, based in Clermont Ferrand (France), focused on discovering and developing new chemical entities, first-in-class analgesic drugs, to treat pain, without inducing many of the side effects associated with current therapies.Their ambition is to develop innovative compounds to reach the human proof of concept (clinical trials phase 2) of efficacy and safety for moderate to severe acute and chronic pain.The development of these compounds, TREK-1 agonists, is the result of their world-class research in pharmacology and medicinal chemistry especially on the involvement of TREK-1 and its direct activation, acting downstream from the µ-opioid receptor (µOR), having strong analgesic effects without opioid-like adverse effects.
